Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer

詳細情報 詳細情報について

• CRID

  1363107368399908992

• DOI

  10.1097/jto.0b013e3182614835

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086415326022?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086415326022?httpAccept=text/plain

• データソース種別

  • Crossref